Heartseed Inc. was founded in 2015 to develop and commercialize cardiac regenerative medicine developed by
Prof. Keiichi Fukuda and his group at the Department of Cardiology, Keio University, Tokyo. Heartseed has
original technologies throughout the process of manufacturing and delivering iPSC-derived cardiac regenerative
medicine, including purification, cell delivery and iPSC production
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.